Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Aug. 31, 2017
Aug. 31, 2016
Operating expenses:    
General and administrative $ 1,569,680 $ 1,580,063
Research and development 8,148,175 3,685,473
Amortization and depreciation 89,146 92,584
Total operating expenses 9,807,001 5,358,120
Operating loss (9,807,001) (5,358,120)
Interest income 787 3,735
Change in fair value of derivative liability (362,666) 0
Interest expense:    
Amortization of discount on convertible notes (444,152)  
Amortization of debt issuance costs (113,700)  
Inducement interest related to warrant exercise (826,252)  
Interest on convertible notes payable (75,289)  
Total interest expense (1,459,393)  
Loss before income taxes (11,628,273) (5,354,385)
Provision for taxes on income 0 0
Net loss $ (11,628,273) $ (5,354,385)
Basic and diluted loss per share $ (0.08) $ (0.04)
Basic and diluted weighted average common shares outstanding 151,738,244 124,411,980